Role of gut microbiota in functional constipation
Open accessThe DOI matches its Crossref record; 102 of the 108 references it cites were found in a registry or an index; 6 of the 64 sources its claims cite were checked for support.
Abstract
Functional constipation (FC) is common, yet the etiology is not clear. Accumulating evidence suggests an association between FC and abnormal gut microbiota. The relationship between the gut microbiota and the gut transit is likely bidirectional. This review summarizes the current evidence regarding the impact of gut microbiota on the pathogenesis of FC. By modulating the colonic motility, secretion, and absorption, gut microbiota may contribute to the development of FC through microbial metabolic activities involving bile acids, short-chain fatty acids, 5-hydroxytryptamine, and methane. In support of the key roles of the gut microbiota in FC, treatment with probiotics, prebiotics, synbiotics, and traditional Chinese medicine often result in compositional and functional changes in the gut microbiota. Further studies on the pathogenesis of FC and the therapeutic mechanism of microecological agents will provide a knowledge base for better management of FC.
Overview
CoChat Summary
TL;DR
This review argues that gut microbiota dysbiosis is an important feature of functional constipation (FC) and may contribute to FC through microbial metabolites including bile acids, short-chain fatty acids, 5-HT, and methane. It also summarizes evidence that probiotics, prebiotics, synbiotics, and traditional Chinese medicine can improve FC partly by changing gut microbiota.
Key findings
- In a demographic survey of 6,300 cases from three countries, FC prevalence by Rome IV criteria was 6.9% in the USA, 7.9% in Canada, and 8.6% in the UK; a global estimate from 1947–2010 was 14%.
- The paper reports inconsistent microbiota profiles across studies: in adolescent FC, Prevotella decreased and Coprococcus, Ruminococcus, Blautia, Anaerotruncus, and Clostridium increased; in adult FC, other studies found decreased Bifidobacterium/Lactobacillus or depletion of Bacteroides, Roseburia, and Coprococcus 3.
- For microbial metabolites, the review states that FC stool studies found fecal acetate 2.2-fold higher than controls, and that acetate, butyrate, and propionate were associated with transit time; it also notes reports of elevated SCFAs and methanogenic bacteria enrichment in FC, but says evidence is inconsistent.
- Intervention evidence summarized in the review suggests probiotics can improve whole-gut transit time, stool frequency, stool consistency, and bloating in meta-analyses, while one double-blind trial found no primary difference vs placebo but a post hoc benefit for B. animalis subsp. lactis HN019 on spontaneous defecation frequency and straining.
Methods
- Narrative review of the literature on gut microbiota and functional constipation, with emphasis on human observational studies, animal studies, and intervention trials.
- The paper compares findings from culture-based studies, qPCR, 16S rRNA sequencing, and whole-genome sequencing studies, and also summarizes randomized trials and meta-analyses of microbiota-targeted therapies.
- The review’s main analysis is mechanistic synthesis, organizing evidence around bile acids, SCFAs, 5-HT, methane, and microbiota-directed treatments.
Limitations
- The paper states that there is no consensus on the gut microbial structure characteristic of FC, and that inconsistent findings may reflect cultural and demographical differences, different analysis techniques, and possible evolution of disease over time.
- It explicitly warns that several mechanistic findings from mouse studies remain to be validated in humans, and that the very different diet and gut microbiota of laboratory animals vs humans limit translation.
- Evident from the text: many intervention and mechanistic studies are described as having small sample sizes, and the review repeatedly notes that several proposed mechanisms and treatments still need adequately powered clinical trials.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
5 Valid · 1 Not valid · 38 Not checked · 18 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“BAs are known to stimulate the release of 5-hydroxytryptamine (5-HT) and calcitonin gene-related peptide from enterochromaffin cells and intrinsic primary afferent neurons by activating the G protein-coupled BA receptor (TGR5), leading to the bowel peristaltic reflex [ 38 , 39 ].”
What the sources say
- Could not verifycites [38] Begley, 2006, Bile salt hydrolase activity in probiotics, Appl Environ Microbiol sourceExperimental — accuracy not yet measured
The BILE discussion and the passage on enterohepatic recirculation and bile salt hydrolase (page not provided) describe bile composition and bacterial modification, not the claimed signaling pathway. Searches for TGR5, 5-hydroxytryptamine, calcitonin gene-related peptide, and the peristaltic reflex found no passage addressing the claim in our copy. (LLM, conf=0.76)
- Supportedcites [39] Bunnett, 2014, Neuro-humoral signalling by bile acids and the TGR5 receptor in the gastrointestinal tract, J Physiol source
The Introduction states that bile acids activate TGR5 on enterochromaffin cells and intrinsic primary afferent neurons, stimulating release of 5-HT and CGRP. It then describes CGRP as transmitting the peristaltic reflex. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“Although it is a controversial subject, a significant amount of evidence suggests that 5-HT stimulates colonic motility through its receptors 5-HT3 and 5-HT4 [ 63 ].”
What the sources say
- Supportedcites [63] Kendig, 2015, Serotonin and colonic motility, Neurogastroenterol Motil source
In 'THE PERISTALTIC REFLEX, PERISTALSIS, AND MUCOSAL SEROTONIN' the paper summarizes the evidence for mucosal 5-HT explicitly by receptor subtype: 5-HT3 and/or 5-HT4 agonists applied to the mucosa or perfused intraluminally 'induce or augment peristalsis and propulsion', while 5-HT3/5-HT4 antagonists inhibit the mucosally induced peristaltic reflex (citing refs 25-27, incl. Jin et al. 1999 'Propulsion in guinea pig colon induced by 5-HT via 5-HT4 and 5-HT3 receptors' and Kadowaki et al. 1996 on guinea pig distal colon). The Conclusions state that studies in mice, rat and other species 'clearly implicate 5-HT3 and 5-HT4 receptors in CMMCs', and the Abstract/Introduction frame the topic as contested, matching the citing sentence's 'although it is a controversial subject... evidence suggests'. The hedged phrasing of the claim is consistent with the source's own level of confidence. (LLM, conf=0.88)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Butyrate-producing genera, Roseburia and Faecalibacterium , were increased in adolescent FC according to 16S rRNA sequencing studies [ 27 , 62 ].”
What the sources say
- Not checked yetcites [27] Zhu, 2014, Structural changes in the gut microbiome of constipated patients, Physiol Genomics source
- Partly supportedcites [62] Pryde, 2002, The microbiology of butyrate formation in the human colon, FEMS Microbiol Lett sourceExperimental — accuracy not yet measured
Section 3 identifies Roseburia intestinalis and Faecalibacterium prausnitzii as butyrate-producing bacteria and describes 16S rRNA analysis of human-gut isolates. It does not report that either genus increased in adolescents with functional constipation; the searches for adolescent constipation and increased abundance found no such result. (LLM, conf=0.89)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In contrast to the findings of previous studies, conventional probiotic genera Lactobacillus and Bifidobacterium exhibited a trend for increased abundance in FC.”
What the sources say
- Not checked yetcites [27] Zhu, 2014, Structural changes in the gut microbiome of constipated patients, Physiol Genomics source
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“At the community level, increased species richness was observed in the gut of FC”
What the sources say
- Not checked yetcites [27] Zhu, 2014, Structural changes in the gut microbiome of constipated patients, Physiol Genomics source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims
Create a free account to see all 62 claims and to verify the 58 references still open.
- It may state two separate claims as one. 27
- Probably not a substantial claim. 14
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several studies have found that gut microbiota could participate in the development of FC by regulating the enteric nervous system, immune system and intestinal microenvironment through metabolites including bile acids, short-chain fatty acids, 5-hydroxytryptamine and methane.7”
From Efficacy in bowel movement and change of gut microbiota on adult functional constipation patients treated with probiotics-containing products: a systematic review and meta-analysis (2024) · cites this paper as [7]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Obesity and diet greatly influence the composition of the gut microbiota, which might affect the efficacy,7”
In the citing paper
“For instance, SCFAs can reduce the pH value in the intestinal lumen, reduce inf lammation, and promote colonic movement [6,28];”
From Chronic constipation and gut microbiota: current research insights and therapeutic implications (2024) · cites this paper as [28]
In the citing paper
“Furthermore, dysregulated gut microbiota can remove 5-HT from the gut and weaken gut motility by reducing serotonin-producing substrates or upregulating serotonin transporter expression [28].”
From Chronic constipation and gut microbiota: current research insights and therapeutic implications (2024) · cites this paper as [28]
Citations
Cites
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
Gibson, G. R., & Roberfroid, M. B. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.6.1401 · Cited by 7,667 · cited 1×
“Prebiotics refers to non-digestible food ingredients that beneficially affect the host by selectively stimulating the growth and/ or activity of one or a limited number of bacteria in the colon [89].”
BackgroundDe Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., Collini, S., Pieraccini, G., & Lionetti, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005963107 · Cited by 5,579
Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis
Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., Nagler, C. R., Ismagilov, R. F., Mazmanian, S. K., & Hsiao, E. Y. (2015) · Cell · doi:10.1016/j.cell.2015.02.047 · Cited by 3,614
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Agus, A., Planchais, J., & Sokol, H. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.05.003 · Cited by 3,180 · cited 1×
“by regulating tryptophan metabolism in the gut [69].”
BackgroundLacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlström, A., Sayin, S. I., Marschall, H.-U., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,851
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
Drossman, D. A. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.032 · Cited by 2,430
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274 · cited 2×
“CYP7A1 [49, 50], and consequently elevated de novo BA synthesis”
BackgroundSperber, A. D., Bangdiwala, S. I., Drossman, D. A., Ghoshal, U. C., Simren, M., Tack, J., Whitehead, W. E., Dumitrascu, D. L., Fang, X., Fukudo, S., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.04.014 · Cited by 2,263 · cited 1×
“Functional constipation (FC) refers to constipation without an organic etiology [1, 2].”
BackgroundThe pros, cons, and many unknowns of probiotics
Suez, J., Zmora, N., Segal, E., & Elinav, E. (2019) · Nature Medicine · doi:10.1038/s41591-019-0439-x · Cited by 1,398
Research works printed but not linked: 2
- Zhang, 2017, Expert consensus on TCM diagnosis and treatment of constipation, Zhong Yi Za Zhi, 58, 1345
- Yang, 2007, Progress in traditional Chinese medicine treatment of chronic functional constipation, Bei Jing Zhong Yi, 26, 61
Cited by
Sasso, J. M., Ammar, R. M., Tenchov, R., Lemmel, S., Kelber, O., Grieswelle, M., & Zhou, Q. A. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00127 · Cited by 204
Smolińska, S., Popescu, F., & Zemelka‐Wiącek, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113673 · Cited by 227
“These probiotics enhance stool frequency and consistency by modulating gut motility and improving gut barrier function [124].”
Gut commensals and their metabolites in health and disease
Krishnamurthy, H. K., Pereira, M., Bosco, J., George, J., Jayaraman, V., Krishna, K., Wang, T., Bei, K., & Rajasekaran, J. J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1244293 · Cited by 123
“…2017; Ghavami et al., 2018; Chong et al., 2019; Kim et al., 2019; Liu and Dai, 2020; Matijašić et al., 2020; Novakovic et al., 2020; Silva et al., 2020; Xiao et al., 2021; Zhang S. et al., 2021; Caetano and Castelucci, 2022; Hao and Son-Nam, 2022; Khorsand et al., 2022; Rashed et al., 2022).”
BackgroundInfluentialLactobacillus reuteri in digestive system diseases: focus on clinical trials and mechanisms
Peng, Y., Ma, Y., Luo, Z., Jiang, Y.-F., Xu, Z., & Yu, R. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1254198 · Cited by 89
“It is suggested that disruption of the intestinal flora play a role in functional constipation (FC) (Zhang et al., 2021).”
BackgroundGut microbiome affects the response to immunotherapy in non‐small cell lung cancer
Ren, S., Feng, L., Liu, H., Mao, Y., & Yu, Z. (2024) · Thoracic Cancer · doi:10.1111/1759-7714.15303 · Cited by 76
“38 SCFAs are major metabolites produced by intestinal microbial fermentation of dietary fiber.”
Background
Metadata
- Authors
- Zhang, S., Wang, R., Li, D., Zhao, L., & Zhu, L.
- Affiliations
- Capital Medical University (CN)
- Sixth Affiliated Hospital of Sun Yat-sen University (CN)
- Corresponding author
- Zhao, Luqing
- Zhu, Lixin
- Venue
- Gastroenterology Report
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-08-06
- Volume
- 9
- Issue
- 5
- Pages
- 392-401
- ISSN
- 2052-0034 (ISSN-L)
- PMC
- PMC8560038
- OpenAlex
- W3190212528
- Cited by
- 175
- References
- 108
- Citations by year
- 2026: 37 · 2025: 35 · 2024: 45 · 2023: 41 · 2022: 17
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Gastroenterology report (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Clinical Medicine Development Project of Beijing Municipal Administration of Hospitals (ZYLX201411)
- Beijing Nova Program (Z201100006820119)
- Beijing Municipal Science & Technology Commission
- Beijing Science and technology (z181100001718218)
- National Natural Science Foundation of China (81770571)
- Guangdong Province ‘Pearl River Talent Plan’ Innovation and Entrepreneurship Team Project (2019ZT08Y464)
- National Key Clinical Discipline of China
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- functional constipation, gut microbiota, colonic motility, gastrointestinal transit, bile acids, short-chain fatty acids, serotonin, methane, probiotics, prebiotics, synbiotics, traditional Chinese medicine, pathogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of gut microbiota in functional constipation. https://app.cochat.ai/papers/10.1093/gastro/goab035
- The paper
- Zhang, S., Wang, R., Li, D., Zhao, L., & Zhu, L. (2021). Role of gut microbiota in functional constipation. Gastroenterology Report. https://doi.org/10.1093/gastro/goab035
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.